Gad Soffer serves as Executive at Atara Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Gad Soffer has executed 56 insider transactions totaling $2.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 17, 2015 involved exercising options for 2,778 shares valued at $30.6K.
Gad Soffer currently holds 243,966 shares of Atara Biotherapeutics, Inc. (ATRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gad Soffer has been a net seller of ATRA stock. They have purchased $0 and sold $2.5M worth of shares.
Gad Soffer's most recent insider trade was on Aug 17, 2015, when they sold 2,778 shares at $11.00 per share.
Get notified when new Form 4 filings are submitted
| $50.00 |
| Discretionary |
| May 15, 2015 | ATRA | $0 | Option Exercise | 80,128 | $N/A | Discretionary |
| May 15, 2015 | ATRA | $0 | Option Exercise | 22,111 | $N/A | Discretionary |
| May 15, 2015 | ATRA | $1.8M | Payment | 48,851 | $37.30 | Discretionary |
| Jan 16, 2015 | ATRA | $0 | Award | 12,400 | $N/A | Discretionary |